Candel Therapeutics
About:
Candel Therapeutics develops cancer immunotherapies designed to improve the lives of cancer patients and their families.
Website: https://www.candeltx.com
Twitter/X: CandelTx
Top Investors: Sands Capital Ventures, Massachusetts Life Sciences Center, Silicon Valley Bank, Northpond Ventures, PBM Capital Group
Description:
Candel develops cancer immunotherapies designed to improve the lives of cancer patients and their families. The company's immunotherapies focus on preventing the recurrence and progression of cancer with low toxicity level which is well suited for the treatment of less aggressive or slower growing cancers such as newly diagnosed prostate cancer, enabling physicians to ensure improved outcomes for their patients and help them recover faster.
$165M
$50M to $100M
Needham, Massachusetts, United States
1999-01-01
info(AT)candeltx.com
Estuardo Aguilar-Cordova
11-50
2022-03-01
Public
© 2025 bioDAO.ai